Position in MRK
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,924,129
+$899,349 QoQ
Shares Held
24,309
+26.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MCF Advisors LLC holds $24,166,889 across 16 Drug Manufacturers - General names. MRK ranks #4 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,429 | $5,971,424 | |
| 2 | AMGN |
Amgen Inc
|
11,665 | $4,104,330 | |
| 3 | LLY |
ELI LILLY & Co
|
3,526 | $3,243,109 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
24,309 | $2,924,129 | |
| 5 | ABBV |
AbbVie Inc.
|
13,037 | $2,835,417 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
19,974 | $2,783,776 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,168 | $980,589 | |
| 8 | PFE |
Pfizer Inc
|
32,618 | $915,913 |
All Filings in MRK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,924,129 | 24,309 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,024,780 | 19,236 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,326,177 | 15,801 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,252,786 | 15,826 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,374,494 | 15,313 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,647,388 | 16,560 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,950,960 | 17,180 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $2,091,724 | 16,896 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $2,190,765 | 16,603 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,722,079 | 15,796 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,643,493 | 15,964 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $1,715,849 | 14,870 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $1,558,400 | 14,648 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,256,175 | 11,322 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $938,363 | 10,896 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $968,772 | 10,626 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $844,130 | 10,288 | Shares | Sole | 2022-05-05 | |
| 2021-09-30 | $708,963 | 9,439 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $684,220 | 8,798 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $496,845 | 6,445 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $535,707 | 6,549 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $720,752 | 8,689 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $467,382 | 6,044 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $465,025 | 6,044 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||